Marshall S. Stanton, the SVP of $AORT, sold 1,513 shares of the company on 03-02-2026 for an estimated $57,531. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.6% of their shares of this class of stock. Following this trade, they now own 40,408 shares of this class of $AORT stock.
$AORT Insider Trading Activity
$AORT insiders have traded $AORT stock on the open market 47 times in the past 6 months. Of those trades, 0 have been purchases and 47 have been sales.
Here’s a breakdown of recent trading of $AORT stock by insiders over the last 6 months:
- JAMES P MACKIN (President & CEO) has made 0 purchases and 7 sales selling 163,441 shares for an estimated $7,019,960.
- MARSHALL S. STANTON (SVP, Clinical & MD Affair) has made 0 purchases and 12 sales selling 75,406 shares for an estimated $3,345,751.
- JEAN F HOLLOWAY (SVP, General Counsel) has made 0 purchases and 10 sales selling 45,753 shares for an estimated $2,024,209.
- JOHN E DAVIS (Chief Commercial Officer) has made 0 purchases and 8 sales selling 36,355 shares for an estimated $1,573,152.
- AMY HORTON (VP, Chief Accounting Officer) has made 0 purchases and 6 sales selling 18,404 shares for an estimated $811,654.
- LANCE A BERRY (EVP, COO, CFO & Treasurer) has made 0 purchases and 3 sales selling 14,644 shares for an estimated $544,201.
- ELIZABETH A HOFF sold 4,200 shares for an estimated $189,411
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AORT Hedge Fund Activity
We have seen 124 institutional investors add shares of $AORT stock to their portfolio, and 109 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 2,483,842 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $113,288,033
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC added 863,867 shares (+inf%) to their portfolio in Q4 2025, for an estimated $39,400,973
- INVESCO LTD. added 748,119 shares (+211.9%) to their portfolio in Q4 2025, for an estimated $34,121,707
- FMR LLC removed 446,294 shares (-14.9%) from their portfolio in Q4 2025, for an estimated $20,355,469
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 423,053 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $19,295,447
- OPHIR ASSET MANAGEMENT PTY LTD removed 413,766 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $18,871,867
- BLACKROCK, INC. added 318,474 shares (+5.3%) to their portfolio in Q4 2025, for an estimated $14,525,599
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AORT Revenue
$AORT had revenues of $116M in Q4 2025. This is an increase of 19.2% from the same period in the prior year.
You can track AORT financials on Quiver Quantitative's AORT stock page.
$AORT Congressional Stock Trading
Members of Congress have traded $AORT stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $AORT stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 10/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$AORT Analyst Ratings
Wall Street analysts have issued reports on $AORT in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 11/07/2025
- Citizens issued a "Market Outperform" rating on 11/07/2025
- Canaccord Genuity issued a "Buy" rating on 11/07/2025
- JMP Securities issued a "Market Outperform" rating on 10/10/2025
- Stifel issued a "Buy" rating on 09/29/2025
To track analyst ratings and price targets for $AORT, check out Quiver Quantitative's $AORT forecast page.
$AORT Price Targets
Multiple analysts have issued price targets for $AORT recently. We have seen 5 analysts offer price targets for $AORT in the last 6 months, with a median target of $48.0.
Here are some recent targets:
- William Plovanic from Canaccord Genuity set a target price of $48.0 on 02/13/2026
- Mike Matson from Needham set a target price of $58.0 on 02/02/2026
- Daniel Stauder from Citizens set a target price of $53.0 on 11/07/2025
- Daniel Stauder from JMP Securities set a target price of $47.0 on 10/10/2025
- Rick Wise from Stifel set a target price of $46.0 on 09/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
